Hernandez-Richter T, Heiss M M, Bubb C, Jauch K W
Chirurgische Klinik und Polikliniken, Klinikum Grosshadern, Ludwig-Maximilians-Universität München.
Langenbecks Arch Chir. 1996;381(5):295-8. doi: 10.1007/BF00184052.
The causal agent for sarcomas is mostly unknown. Unlike solid epithelial carcinomas, the correlation to the exposition to carcinogenic agents is unknown. Besides hereditary neurofibromatosis ("Recklinghausen"), radiation therapy has been reported to induce malignant tumors. In this retrospective study during the last 10 years we observed that in 7 of 356 (approximately 2%) patients treated for sarcomas in our Department of Surgery, the sarcoma was located in the area where radiation therapy had been given earlier for another primary malignant tumor. The interval between this radiation therapy and the diagnosis of sarcoma was 9 to 30 years, corroborated by findings in the literature based on approximately 100 radiation-induced tumors. The median survival time after diagnosis of sarcoma was 3 years. Because radiation therapy is often used in the treatment of malignant tumors this late complication is a clinically relevant problem in long-time survival.
肉瘤的致病因素大多未知。与实体上皮癌不同,其与接触致癌物质的关联尚不清楚。除了遗传性神经纤维瘤病(“雷克林豪森病”)外,据报道放射治疗可诱发恶性肿瘤。在这项过去10年的回顾性研究中,我们观察到,在我们外科治疗的356例肉瘤患者中,有7例(约2%)的肉瘤位于先前因另一种原发性恶性肿瘤而接受放射治疗的区域。此次放射治疗与肉瘤诊断之间的间隔为9至30年,基于约100例放射诱发肿瘤的文献研究结果也证实了这一点。肉瘤诊断后的中位生存时间为3年。由于放射治疗常用于恶性肿瘤的治疗,这种晚期并发症是长期生存中一个具有临床相关性的问题。